Answers are grounded in this paper and cite their sources.
Scientific and therapeutic advances related to hepatitis C virus (HCV) are cause for optimism about the care of HCV-infected patients, but the true rate-limiting step in achieving better outcomes may turn out to be access to diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: